Abstract
Hospital readmissions represent a persistent challenge for healthcare systems, often stemming from inadequate post-discharge monitoring. This study presents a Machine Learning (ML)-driven Clinical Decision Support System (CDSS) designed to enhance nursing risk assessment in post-discharge care.
Developed using a Design Science Research Methodology, the artefact integrates a digital questionnaire, an ML-based risk stratification model, and a real-time dashboard to optimise follow-up processes. The system was developed at a medical-surgical inpatient unit of a private hospital in Portugal. A retrospective dataset of 10,134 structured telephone follow-up records, classified by nurses into three risk levels—stable (A), requiring reassessment (B), and clinically concerning (C)—was used to train and evaluate the ML model.
Among the evaluated classifiers, Logistic Regression was selected for deployment based on its high specificity (0.9993), precision (0.9879), and absence of critical false negatives, despite slightly lower recall compared to XGBoost. The CDSS enables real-time risk classification based on patient-reported outcomes, supporting timely identification and prioritisation of patients requiring clinical attention. Simulation results indicate a potential reduction of up to 79% in nurse follow-up workload, while preserving care quality by focusing resources on moderate- and high-risk patients. Although direct evidence of reduced readmissions is not yet available, the system aligns with established best practices in transitional care. This study demonstrates the feasibility and utility of ML-based dynamic risk stratification for post-discharge monitoring, offering a scalable and interpretable solution that enhances clinical decision-making and resource allocation in nursing practice.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not received specific funding. Authors acknowledge Fundacao para a Ciencia e a Tecnologia I.P. for its financial support via the project UID/00667: Unidade de Investigacao e Desenvolvimento em Engenharia Mecanica e Industrial. MP was supported by FCT (2023.00994.BD).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was granted by the Administration and Clinical Directorate of Hospital Lusíadas Amadora, as well as the Ethics Committee for Health of Hospital Lusíadas Amadora. All data were anonymised before analysis and managed in accordance with the General Data Protection Regulation (GDPR).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
